Menu
GeneBe

SRA1

steroid receptor RNA activator 1

Basic information

Region (hg38): 5:140537339-140557677

Links

ENSG00000213523NCBI:10011OMIM:603819HGNC:11281Uniprot:Q9HD15AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SRA1 gene.

  • not provided (37 variants)
  • Inborn genetic diseases (16 variants)
  • not specified (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SRA1 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
4
clinvar
5
clinvar
9
missense
20
clinvar
6
clinvar
4
clinvar
30
nonsense
0
start loss
0
frameshift
2
clinvar
2
inframe indel
1
clinvar
1
splice donor/acceptor (+/-2bp)
0
splice region
1
1
1
3
non coding
2
clinvar
1
clinvar
5
clinvar
8
Total 0 0 22 11 17

Variants in SRA1

This is a list of pathogenic ClinVar variants found in the SRA1 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
5-140537517-C-G Benign (Apr 05, 2018)775225
5-140539380-C-T not specified Uncertain significance (Apr 07, 2023)2535098
5-140542185-C-T not specified Uncertain significance (Jun 11, 2021)2382638
5-140542220-C-A not specified Uncertain significance (Oct 10, 2023)3121032
5-140542220-C-G not specified Uncertain significance (Mar 16, 2022)2344474
5-140542238-A-G not specified Uncertain significance (Sep 20, 2023)3121034
5-140542253-C-T not specified Uncertain significance (Aug 12, 2021)2220182
5-140547801-A-C not specified Uncertain significance (Apr 13, 2022)2388992
5-140548907-C-A not specified Uncertain significance (Feb 28, 2024)3121044
5-140548926-C-T not specified Uncertain significance (Jan 04, 2024)3121049
5-140548927-G-A not specified Uncertain significance (Aug 10, 2021)2242250
5-140548928-A-C not specified Uncertain significance (Jan 20, 2023)2476991
5-140548997-C-T not specified Uncertain significance (Dec 05, 2022)2224332
5-140548999-G-A not specified Uncertain significance (Jul 14, 2021)2237325
5-140549026-T-C not specified Likely benign (Feb 13, 2023)2483070
5-140549053-A-T not specified Uncertain significance (Sep 30, 2021)2354989
5-140549057-G-A not specified Uncertain significance (Jun 06, 2023)2558174
5-140550722-G-A SRA1-related disorder Benign (Nov 27, 2023)785142
5-140550729-T-C not specified Uncertain significance (Jun 11, 2021)2232202
5-140550778-C-G not specified Uncertain significance (Aug 17, 2021)3169803
5-140550795-T-C Likely benign (Mar 08, 2023)1538263
5-140550803-G-A not specified Uncertain significance (Jan 04, 2022)2269276
5-140550811-T-C Likely benign (Aug 19, 2022)2189939
5-140550861-T-C not specified Uncertain significance (Aug 13, 2021)2386983
5-140550869-C-T not specified Uncertain significance (Mar 14, 2023)2495914

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SRA1protein_codingprotein_codingENST00000336283 520971
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.000005190.4381257210271257480.000107
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense-0.3311421311.080.000006791472
Missense in Polyphen5951.5241.1451621
Synonymous-0.2085250.11.040.00000245479
Loss of Function0.535910.90.8255.50e-7120

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00009050.0000904
Ashkenazi Jewish0.00009930.0000992
East Asian0.0001640.000163
Finnish0.000.00
European (Non-Finnish)0.0001420.000141
Middle Eastern0.0001640.000163
South Asian0.0001630.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Functional RNA which acts as a transcriptional coactivator that selectively enhances steroid receptor-mediated transactivation ligand-independently through a mechanism involving the modulating N-terminal domain (AF-1) of steroid receptors. Also mediates transcriptional coactivation of steroid receptors ligand- dependently through the steroid-binding domain (AF-2). Enhances cellular proliferation and differentiation and promotes apoptosis in vivo. May play a role in tumorigenesis. {ECO:0000269|PubMed:10199399, ECO:0000269|PubMed:12943696, ECO:0000269|PubMed:14517287, ECO:0000269|PubMed:15147866, ECO:0000269|PubMed:15351741}.;
Pathway
mechanism of gene regulation by peroxisome proliferators via ppara;Validated nuclear estrogen receptor alpha network (Consensus)

Recessive Scores

pRec
0.0882

Intolerance Scores

loftool
0.966
rvis_EVS
0.6
rvis_percentile_EVS
82.66

Haploinsufficiency Scores

pHI
0.358
hipred
Y
hipred_score
0.550
ghis
0.429

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
1.00

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh

Mouse Genome Informatics

Gene name
Sra1
Phenotype
nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; renal/urinary system phenotype; liver/biliary system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); craniofacial phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan);

Zebrafish Information Network

Gene name
sra1
Affected structure
pericardium
Phenotype tag
abnormal
Phenotype quality
edematous

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;apoptotic process;cell population proliferation;cell differentiation;regulation of apoptotic process;negative regulation of myoblast differentiation;cellular response to estrogen stimulus;positive regulation of nucleic acid-templated transcription
Cellular component
nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;microtubule cytoskeleton;intercellular bridge;ribonucleoprotein complex
Molecular function
steroid receptor RNA activator RNA binding;transcription coactivator activity;protein binding;nuclear receptor transcription coactivator activity